Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4B | Q07343 | 1/20 | 0.36 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.35 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.34 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.34 |
| ▸ | ABCC1 | P33527 | 1/20 | 0.34 |
| ▸ | HSD17B14 | Q9BPX1 | 1/20 | 0.34 |
| ▸ | MAP3K5 | Q99683 | 1/20 | 0.33 |
| ▸ | FLT3 | P36888 | 1/20 | 0.33 |
| ▸ | P2RX3 | P56373 | 2/20 | 0.33 |
| ▸ | GALR2 | O43603 | 3/20 | 0.32 |
| ▸ | GALR1 | P47211 | 2/20 | 0.32 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.32 |
| ▸ | P2RX7 | Q99572 | 3/20 | 0.31 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.31 |
| ▸ | BRD4 | O60885 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16747941 | 0.86 | ABCG2 (0.33) | SCN9AABCG2ABCB1ABCC1P2RX3 | |
| SCHEMBL18094409 | 0.86 | PDE4B (0.36) | PDE4BSCN9AABCG2ABCB1ABCC1 | |
| SCHEMBL18094405 | 0.76 | FLT3 (0.34) | PDE4BSCN9AABCG2ABCB1ABCC1 | |
| SCHEMBL16740005 | 0.76 | BMI1 (0.40) | SCN9AGALR2GALR1 | |
| SCHEMBL16740266 | 0.76 | BRAF (0.36) | PDE4BSCN9AABCG2ABCB1ABCC1 | |
| SCHEMBL18094395 | 0.76 | SCN9A (0.34) | PDE4BSCN9AHSD17B14FLT3GALR2 | |
| SCHEMBL16740076 | 0.76 | ABCG2 (0.34) | SCN9AABCG2ABCB1ABCC1P2RX3 | |
| SCHEMBL16747893 | 0.75 | AGPAT2 (0.36) | ABCG2ABCB1ABCC1P2RX3GALR2 | |
| SCHEMBL16747938 | 0.75 | GALR2 (0.37) | SCN9AABCG2GALR2GALR1P2RX7 | |
| SCHEMBL16747940 | 0.74 | P2RX3 (0.34) | ABCG2ABCB1ABCC1P2RX3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10584115-B2 | Substituted pyridine and pyrazine BMI-1 inhibitors | PTC THERAPEUTICS, INC. (US) | 2020-03-10 | — | — | US | disclosed |
| US-20160280685-A1 | SUBSTITUTED PYRIDINE AND PYRAZINE BMI-1 INHIBITORS | PTC THERAPEUTICS, INC. | 2016-09-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160280685-A1 | SUBSTITUTED PYRIDINE AND PYRAZINE BMI-1 INHIBITORS | BMI1, BAZ2A, BAZ2B | PDE4B 3693/4885SCN9A 4295/4885ABCG2 4475/4885 |
| US-10584115-B2 | Substituted pyridine and pyrazine BMI-1 inhibitors | BMI1, BAZ2A, BAZ2B | PDE4B 3693/4885SCN9A 4295/4885ABCG2 4475/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.